In a recent study published in Advanced Science, researchers found metabolic activator treatment can reduce recovery time by as many as 3.5 days in people with mild-to-moderate COVID-19.
They also found that treatment with the metabolic activators improved liver health and decreased the levels of inflammation, as shown by inflammatory markers.
The study is from KTH Royal Institute of Technology in Stockholm and was conducted by Adil Mardinoglu et al.
In the study, patients with mild-to-moderate COVID-19 received the combined activators or placebo twice a day for 14 days.
The team showed who were also receiving standard care experienced a 3.5 day reduction in recovery time when receiving the combination of metabolic activators: nicotinamide riboside (NR), L-serine, N-acetyl-L-cysteine (NAC), and L-carnitine tartrate.
All four activators are aimed at improving mitochondrial function.
The team says that metabolic activators strongly improve the recovery, liver health, and markers of inflammation of patients with COVID-19.
Dysfunctional mitochondria have been implicated in worsened progression for COVID-19.
The researchers are pleased to find that the combination of these metabolic activators helps to remedy the stress put on the body of an infected patient.
Sign up for our newsletter for more information about this topic.
If you care about COVID, please read studies about new treatment option for COVID-19, and vitamin D deficiency linked to severe COVID-19 and death.
For more information about COVID, please see recent studies about a universal antibody therapy for all COVID-19 variants, and results showing this new oral drug may prevent death from COVID-19.
Copyright © 2022 Knowridge Science Report. All rights reserved.
